Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ASNB
EKIMAS
$0.61
$0.56
$0.55
$1.75
$3.54M0.373,162 shsN/A
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
$0.00
$0.00
$0.00
$0.00
$10K-2.354,409 shsN/A
Regenicin, Inc. stock logo
RGIN
Regenicin
$0.01
$0.00
$0.00
$0.01
$829KN/A6,286 shsN/A
United American Healthcare Co. stock logo
UAHC
United American Healthcare
$0.03
$0.03
$0.02
$0.05
$3.12M-1.421,023 shsN/A
QHSLab, Inc. stock logo
USAQ
QHSLab
$0.09
+5.0%
$0.08
$0.02
$0.25
$920K-0.2325,969 shs37,215 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ASNB
EKIMAS
0.00%0.00%0.00%+12.96%-24.69%
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
0.00%0.00%-80.00%-84.62%-95.56%
Regenicin, Inc. stock logo
RGIN
Regenicin
0.00%0.00%+4,900.00%+4,900.00%+233.33%
United American Healthcare Co. stock logo
UAHC
United American Healthcare
0.00%+0.09%+15.26%+17.81%+56.62%
QHSLab, Inc. stock logo
USAQ
QHSLab
0.00%+47.54%+47.54%-24.37%-34.45%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ASNB
EKIMAS
N/AN/AN/AN/AN/AN/AN/AN/A
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
N/AN/AN/AN/AN/AN/AN/AN/A
Regenicin, Inc. stock logo
RGIN
Regenicin
N/AN/AN/AN/AN/AN/AN/AN/A
United American Healthcare Co. stock logo
UAHC
United American Healthcare
N/AN/AN/AN/AN/AN/AN/AN/A
QHSLab, Inc. stock logo
USAQ
QHSLab
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ASNB
EKIMAS
N/AN/AN/AN/A
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
N/AN/AN/AN/A
Regenicin, Inc. stock logo
RGIN
Regenicin
N/AN/AN/AN/A
United American Healthcare Co. stock logo
UAHC
United American Healthcare
N/AN/AN/AN/A
QHSLab, Inc. stock logo
USAQ
QHSLab
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ASNB
EKIMAS
N/AN/AN/AN/A$0.03 per shareN/A
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
N/AN/AN/AN/AN/AN/A
Regenicin, Inc. stock logo
RGIN
Regenicin
N/AN/AN/AN/A($0.04) per shareN/A
United American Healthcare Co. stock logo
UAHC
United American Healthcare
N/AN/AN/AN/AN/AN/A
QHSLab, Inc. stock logo
USAQ
QHSLab
$1.41M0.65N/AN/A($0.04) per share-2.36

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ASNB
EKIMAS
-$290KN/A0.00N/AN/A-7,902.31%-5,274.01%N/A
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
N/AN/A0.00N/AN/AN/AN/AN/A
Regenicin, Inc. stock logo
RGIN
Regenicin
-$640KN/A0.00N/AN/AN/AN/AN/A
United American Healthcare Co. stock logo
UAHC
United American Healthcare
N/AN/A0.00N/AN/AN/AN/AN/A
QHSLab, Inc. stock logo
USAQ
QHSLab
-$470KN/A0.00N/A-33.27%N/A-26.37%N/A

Latest USAQ, UAHC, RGIN, HDII, and ASNB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/27/2024Q4 2023
QHSLab, Inc. stock logo
USAQ
QHSLab
N/A-$0.01-$0.01-$0.01N/A$0.32 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ASNB
EKIMAS
N/AN/AN/AN/AN/A
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
N/AN/AN/AN/AN/A
Regenicin, Inc. stock logo
RGIN
Regenicin
N/AN/AN/AN/AN/A
United American Healthcare Co. stock logo
UAHC
United American Healthcare
N/AN/AN/AN/AN/A
QHSLab, Inc. stock logo
USAQ
QHSLab
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ASNB
EKIMAS
N/A
0.12
0.12
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
N/AN/AN/A
Regenicin, Inc. stock logo
RGIN
Regenicin
N/AN/AN/A
United American Healthcare Co. stock logo
UAHC
United American Healthcare
N/AN/AN/A
QHSLab, Inc. stock logo
USAQ
QHSLab
N/A
0.08
0.06

Ownership

Institutional Ownership

CompanyInstitutional Ownership
ASNB
EKIMAS
N/A
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
N/A
Regenicin, Inc. stock logo
RGIN
Regenicin
0.01%
United American Healthcare Co. stock logo
UAHC
United American Healthcare
N/A
QHSLab, Inc. stock logo
USAQ
QHSLab
N/A

Insider Ownership

CompanyInsider Ownership
ASNB
EKIMAS
7.80%
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
40.00%
Regenicin, Inc. stock logo
RGIN
Regenicin
N/A
United American Healthcare Co. stock logo
UAHC
United American Healthcare
14.31%
QHSLab, Inc. stock logo
USAQ
QHSLab
74.19%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ASNB
EKIMAS
115.80 million5.35 millionNot Optionable
Hypertension Diagnostics, Inc. stock logo
HDII
Hypertension Diagnostics
2,01752.39 millionN/ANot Optionable
Regenicin, Inc. stock logo
RGIN
Regenicin
3165.77 millionN/ANot Optionable
United American Healthcare Co. stock logo
UAHC
United American Healthcare
33117.06 million100.31 millionNot Optionable
QHSLab, Inc. stock logo
USAQ
QHSLab
49.74 million2.51 millionNot Optionable

USAQ, UAHC, RGIN, HDII, and ASNB Headlines

SourceHeadline
QHSLab, Inc. Announces Preliminary Unaudited First Quarter Revenue ResultsQHSLab, Inc. Announces Preliminary Unaudited First Quarter Revenue Results
globenewswire.com - April 26 at 8:30 AM
Short Interest in QHSLab, Inc. (OTCMKTS:USAQ) Declines By 91.2%Short Interest in QHSLab, Inc. (OTCMKTS:USAQ) Declines By 91.2%
americanbankingnews.com - April 26 at 5:54 AM
USA TODAY HomefrontUSA TODAY Homefront
usatoday.com - April 24 at 12:42 AM
About Us | Todays latest from Al JazeeraAbout Us | Today's latest from Al Jazeera
aljazeera.com - April 2 at 10:34 PM
The full list of major US companies slashing staff this year, from IBM to Google and MicrosoftThe full list of major US companies slashing staff this year, from IBM to Google and Microsoft
businessinsider.com - March 30 at 1:52 AM
QHSLab Announces Impressive 2023 Fiscal Year Results with Growing Revenues, Improved Gross Margins, and Substantial Reduction in Net LossQHSLab Announces Impressive 2023 Fiscal Year Results with Growing Revenues, Improved Gross Margins, and Substantial Reduction in Net Loss
globenewswire.com - March 28 at 8:00 AM
Orange County high school Artist of the Year 2024: Theater nomineesOrange County high school Artist of the Year 2024: Theater nominees
ocregister.com - March 17 at 3:14 PM
The Old Guy: On local theater, Alcoholics Anonymous and finding a safe placeThe Old Guy: On local theater, Alcoholics Anonymous and finding a safe place
silive.com - March 2 at 3:14 PM
US ElectionsUS Elections
reuters.com - February 23 at 5:33 AM
US NEWSUS NEWS
timesofindia.indiatimes.com - February 9 at 8:20 PM
QHSLab Integrates Digital Medicine Assessments into Prominent Electronic Health Record (EHR) CompanyQHSLab Integrates Digital Medicine Assessments into Prominent Electronic Health Record (EHR) Company
finance.yahoo.com - January 30 at 9:40 AM
US Dollar Index (DXY) Price Value Chart TodayUS Dollar Index (DXY) Price Value Chart Today
dailyfx.com - January 6 at 1:32 PM
Best Travel Medical Insurance For Visitors To The USA Of 2024Best Travel Medical Insurance For Visitors To The USA Of 2024
forbes.com - January 4 at 12:24 PM
Top 100: Updated USA TODAY High School Sports 2024 composite recruiting rankingsTop 100: Updated USA TODAY High School Sports 2024 composite recruiting rankings
usatodayhss.com - January 3 at 11:20 AM
NewDay USA ReviewsNewDay USA Reviews
consumeraffairs.com - December 17 at 9:42 PM
US hate crime highest in more than a decade - FBIUS hate crime highest in more than a decade - FBI
bbc.com - December 14 at 3:48 PM
QHSLab reports Q3 resultsQHSLab reports Q3 results
msn.com - November 14 at 3:26 PM
QHSLab, Inc. (USAQ) Reports Third Quarter Financial ResultsQHSLab, Inc. (USAQ) Reports Third Quarter Financial Results
finance.yahoo.com - November 14 at 10:26 AM
US OpenUS Open
express.co.uk - November 10 at 3:04 PM
Us & ThemUs & Them
npr.org - November 9 at 6:02 PM
QHSLab Welcomes Six New Integrated Service Program (ISP) Customer Accounts and Launches Enhanced Website for Improved Customer EngagementQHSLab Welcomes Six New Integrated Service Program (ISP) Customer Accounts and Launches Enhanced Website for Improved Customer Engagement
finance.yahoo.com - October 25 at 10:05 AM
QHSLab Continues to Lead the Way in Digital Healthcare with Impressive Year-to-Date Achievements in Patient-Centric Innovations and Advancements in Behavioral HealthcareQHSLab Continues to Lead the Way in Digital Healthcare with Impressive Year-to-Date Achievements in Patient-Centric Innovations and Advancements in Behavioral Healthcare
finance.yahoo.com - October 18 at 8:55 AM
Miss Utah crowned Miss USA 2023Miss Utah crowned Miss USA 2023
fox13now.com - October 2 at 7:34 PM
When is the Ryder Cup? Everything you need to know about USA vs. Europe in golfWhen is the Ryder Cup? Everything you need to know about USA vs. Europe in golf
usatoday.com - September 27 at 1:26 AM

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

EKIMAS

OTCMKTS:ASNB
EKIMAS Corp. engages in the development of polymer materials, which provide characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. The firm's products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend. The company was founded in 1993 and is headquartered in Las Vegas, NV.
Hypertension Diagnostics logo

Hypertension Diagnostics

OTCMKTS:HDII
Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company offers CVProfilor DO-2020, which provides a patient's arterial elasticity indices used in the assessment for underlying vascular disease; CVProfilor MD-3000 that offers a sensitive and specific guide to the presence of blood vessel disease; and HD/PulseWave CR-2000 research cardiovascular profiling system, which provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in various areas. Its products collect 30 seconds of blood pressure waveform data, perform an analysis of the digitized blood pressure waveforms, and generate a CVProfile report that contains information on blood pressure, heart rate, pulse pressure, body surface area, body mass index, and C1-large and C2-small artery elasticity indices. The company sells its products to primary care physicians, cardiologists, health care professionals, trained medical personnel, research investigators at academic medical research centers, government institutes, cardiovascular specialists, and pharmaceutical firms. It markets its products through a representative organization in the United States. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada.
Regenicin logo

Regenicin

OTCMKTS:RGIN
Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.
United American Healthcare logo

United American Healthcare

OTCMKTS:UAHC
United American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois.
QHSLab logo

QHSLab

OTCMKTS:USAQ
QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It also develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. In addition, the company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida.